Skip to main content
. 2022 Apr 18;14(4):881. doi: 10.3390/pharmaceutics14040881

Figure 7.

Figure 7

Representative images of gel retardation assay for evaluating the ability of the peptides to protect siRNA from 25% FBS after 24 h treatment. The gel was run after dissociating the peptides/siRNA complexes using a heparin competition assay.